Michael R Hayden Aurinia Pharmaceuticals Inc. (AUPH) insider trading activity

AUPH Quotes by TradingView

Michael R Hayden is Director of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 95,000 shares of AUPH, which is worth approximately $857,849. The most recent transaction as insider was on Jan 29, 2021, when has been sold 95,000 shares (Common Shares) at a price of $5.97 per share, resulting in proceeds of $567,150. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 95K
0% 3M change
0% 12M change
Total Value Held $857,849

Michael R Hayden Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 29 2021
BUY
Exercise of conversion of derivative security
$567,150 $5.97 p/Share
95,000 Added 50.0%
95,000 Common Shares

Also insider at

IONS
IONIS PHARMACEUTICALS INC Healthcare
Director
ABCL
AbCellera Biologics Inc. Healthcare
Director
XENE
Xenon Pharmaceuticals Inc. Healthcare
Director
ETNB
89bio, Inc. Healthcare
MRH

Michael R Hayden

Director
Carlsbad, CA

Track Institutional and Insider Activities on AUPH

Follow Aurinia Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUPH shares.

Notify only if

Insider Trading

Get notified when an Aurinia Pharmaceuticals Inc. insider buys or sells AUPH shares.

Notify only if

News

Receive news related to Aurinia Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AUPH